
Bioinvent International AB (PK) (BOVNF)
USOTC
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Revenue | 45.01M | 38.55M | 93.74M | 147.37M | 19.38M | 326.13M | 71.46M | 44.69M |
Operating Income | -100.61M | -123.08M | -137M | -74.96M | -278.17M | -50.47M | -370.56M | -471.25M |
Pre Tax Income | -100.53M | -123.16M | -138.63M | -76.33M | -278.44M | -42.5M | -330.1M | -429.24M |
Net Income | -100.53M | -123.16M | -138.63M | -76.33M | -278.44M | -42.5M | -330.3M | -429.38M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.33 | -0.351 | -0.276 | -1.939 | -4.762 | -0.654 | -5.02 | -6.525 |
EBIT | -100.61M | -123.08M | -137M | -74.96M | -278.17M | -50.47M | -370.56M | -471.25M |
EBITDA | -97.73M | -118.02M | -125.39M | -62.95M | -263.56M | -35.75M | -353.8M | -451.95M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.